Valirx Plc

Valirx (VAL)

Company name:Valirx Plc
EPIC:VALTrading Currency:GBX
Market Sector:AIMPISIN:GB00BLH13C52
Market Segment:ASX1Share Type:DE
WWW Address: 0.1P
 Price Price Change [%] Bid Offer Open High Low Volume
 21.50 0.0 [0.00] 21.00 22.00 21.50 21.50 21.25 282,199
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 13.95 64.88 -0.04 -0.26 - - - 67.50 - 3.88

Valirx Key Figures

(at previous day's close)
Market Cap.13.95m
Shares In Issue64.88m
Prev. Close21.50
PE Ratio- 
Dividend Yield-%
EPS - basic-0.26p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-2.07p
Return On Equity (ROE)-103.05%
Operating Margin-%
PEG Factor- 
EPS Growth Rate72.34%
Dividends PS Growth Rate-%
Net Debt1.38m
Gross Gearing38.33%
Quick Assets0.38m
Net Working Capital-1.00m
Intangibles / Fixed Assets100.00%
Turnover PS-p
Pre-Tax Profit PS-4.19p
Retained Profit PS-3.74p
Cash PS-p
Net Cash PS-2.13p
Net Tangible Asset Value PS *-1.34p
Net Asset Value PS3.43p
Spread1.00 (4.55%) 

Valirx Balance Sheet


Share Price Performance

Sample Period HighLow
1 week21.5019.25
4 weeks22.2519.25
12 weeks26.7519.25
1 year67.503.88

Share Price Chart (5 years)

Valirx Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week20.501.004.8819.250.3720.51
4 weeks22.25-0.75-3.3719.250.3920.74
12 weeks25.00-3.50-14.0019.250.7222.39
26 weeks24.75-3.25-13.1318.501.0123.50
1 year4.0017.50437.503.882.4423.03
3 years125.00-103.50-82.801.409.5217.25
5 years350.00-328.50-93.861.407.6251.24

Valirx Key Management Ratios

Valirx Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 3.56 
Tobin's Q Ratio (excl. intangibles)20.07 
Dividend Yield-%
Market-to-Book Ratio5.93 
Price-to-Pre-Tax Profit PS-5.13 
Price-to-Retained Profit PS-5.75 
Price-to-Cash Flow PS-10.40 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS-13.95 
Price-to-Cash PS- 
Net Working Capital PS-1.54 
Price Pct to Working Capital PS-13.95%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Valirx Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing38.33%
Net Gearing (excl. Intangibles)361.77%
Gross Gearing38.33%
Gross Gearing (excl. Intangibles)361.77%
Gearing Under 1 Year38.33%
Gearing Under 1 Year (excl. Intgbl)361.77%
(Liquidity Ratios)
Net Working Capital to Total Assets-27.73%
Current Ratio0.28 
Quick Ratio (Acid Test)0.28 
Liquidity Ratio- 
Cash & Equiv/Current Assets-%
(Solvency Ratios)
Enterprise Value13.82m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.10 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.51 
Total Debt1.38m
Total Debt/Net Current Assets-1.38%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-48.47%
5 yr Compound Earnings Growth-47.72%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs6 
Beta (60-Mnth)Beta (36-Mnth)

Valirx Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-122.33%
Return On Assets (ROA)-61.89%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-103.05%
Return On Investment (ROI)-92.34%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debt Collection Period-Days

Valirx Dividends

Sorry No Data Available

Valirx Fundamentals

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
pre tax profit-5.75--3.55--4.83--2.72-m
attributable profit-4.75--3.14--4.37--2.43-m
retained profit-4.75--3.14--4.37--2.43-m
eps - basic (p)-8.54 -1.90 -0.94 -0.26 
eps - diluted (p)-8.54 -1.90 -0.94 -0.26 
dividends per share- - - - 

Valirx Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
fixed assets fixed assets0.010.21%--%--%--%m
intangibles intangibles2.8256.92%2.9359.30%3.2376.19%3.2289.41%m
fixed investments fixed investments0.142.84%0.122.37%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors1.4328.73%1.1924.12%0.6415.00%0.3810.59%m
cash & securities cash & securities0.5611.30%0.7014.21%0.378.81%--%m
creditors - short creditors - short2.5952.25%1.7836.14%1.2028.42%1.3838.33%m
creditors - long creditors - long--%--%--%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves2.3547.36%3.1864.36%3.1273.79%2.3565.30%m
prefs, minorities prefs, minorities0.020.40%-0.02-0.50%-0.09-2.21%-0.13-3.63%m
NAV Basic- - - - 
NAV Diluted- - - - 

Valirx Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF-4.59-2.35-3.35-1.34m
Pre-Financing CF-4.59-2.56-3.68-1.59m
Retained CF0.330.14-0.33-0.38m

Valirx Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Liberum Capital LimitedMarket Maker(MMF)Broker/DealerLIBCLCAPGB21
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210422 18:24:20